Monday, September 14, 2026

Kim’s Quiet Show of Force: North Korea Launches Missiles Amid Tensions

North Korea launched multiple short-range ballistic missiles without media coverage, likely to signal defiance amid rising tensions.

Too Good to Be True? Cheap YouTube Subscriptions Now a Big Problem

Seoul warns against YouTube account-sharing scams following a rise in consumer complaints and account suspensions due to policy violations.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

Tag: gene therapy

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Inventage Lab to present mRNA-LNP large-scale manufacturing platform at CRS 2026

Inventage Lab showcases its IVL-GeneFluidic® platform for mRNA lipid nanoparticles at CRS 2026, enhancing local manufacturing capabilities.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Matica Bio Launches Open Access Platform: A Game Changer for Gene Therapy in 2026

Matica Bio launches an open CDMO platform for gene therapy, enhancing client control and streamlining production with Cirsium Biosciences.

Gene Editing Study Suggests New Treatment Path for Rare Krabbe Disease

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

Samsung’s G-CROWN Platform is Revolutionizing Gene Therapy for Rare Diseases in Asia

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.